Literature DB >> 9919988

Study of acid-base equilibria of fleroxacin.

G Popović1, L Milovanović, V Kapetanović.   

Abstract

The acid-base equilibria of fleroxacin were studied by means of potentiometry and spectrophotometry. It was established that fleroxacin undergoes a complex acid-base equilibrium due to its zwitterionic nature and two proton-binding sites of similar acidity. The stoichiometric equilibrium constants were determined at 25 degrees C and constant ionic strength 0.1 M (NaCl). The acidity constants pK1 = 5.59 +/- 0.01 and pK2 = 8.08 +/- 0.04 were found by potentiometry, and pK1 = 5.61 +/- 0.03 and pK2 = 8.11 +/- 0.06 by spectrophotometry. The distribution diagram of the corresponding ionic species is given.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9919988     DOI: 10.1016/s0731-7085(98)00281-7

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  4 in total

1.  Fluorescence studies of gold(III)-norfloxacin complexes in aqueous solutions.

Authors:  Fabricio C L Luiz; Luciene S Garcia; Luiz S Goes Filho; Leticia R Teixeira; Sonia R W Louro
Journal:  J Fluoresc       Date:  2011-05-15       Impact factor: 2.217

2.  Interaction of the antibiotic norfloxacin with ionic micelles: pH-dependent binding.

Authors:  Gabriel Silva Vignoli Muniz; Letícia Regina Teixeira; Sonia Renaux Wanderley Louro
Journal:  Eur Biophys J       Date:  2014-08-05       Impact factor: 1.733

3.  Effects of Magnesium, Calcium, and Aluminum Chelation on Fluoroquinolone Absorption Rate and Bioavailability: A Computational Study.

Authors:  Daniel M Walden; Maksim Khotimchenko; Hypatia Hou; Kaushik Chakravarty; Jyotika Varshney
Journal:  Pharmaceutics       Date:  2021-04-21       Impact factor: 6.321

4.  Development of a fluorescent immunochromatographic assay based on quantum dots for the detection of fleroxacin.

Authors:  Qingbao Yang; Yanhua Qi; Jingming Zhou; Yumei Chen; Chao Liang; Zhanxiang Liu; Xiaoli Zhang; Aiping Wang
Journal:  RSC Adv       Date:  2021-06-22       Impact factor: 4.036

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.